2023 annual financial data
Cardiol Therapeutics 2023 Operating margin
Cardiol Therapeutics 2023 operating margin with verified reported values.
Direct answer
Operating margin was Not calculable.
Operating income was -22,473,162 CAD and net income was -21,222,796 CAD.
Operating cash flow was -25,180,441 CAD.
Get free Cardiol Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 0 CAD
- Operating income
- -22,473,162 CAD
- Net income
- -21,222,796 CAD
- Operating cash flow
- -25,180,441 CAD